Mount Yale Investment Advisors, LLC Repligen Corp Transaction History

Mount Yale Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$76.65 - $95.51 $172,079 - $214,419	-2,245 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$54.2 - $85.95 $121,679 - $192,957	2,245 New	2,245 $202,000
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $62,255 - $88,855	-1,290 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $1,544 - $1,946	33 Added 2.63%	1,290 $88,000
Q2 2018 Aug 22, 2018	BUY	$35.26 - $47.04 $30,358 - $40,501	861 Added 217.42%	1,257 $59,000
Q1 2018 Jun 25, 2018	BUY	$30.92 - $37.27 $12,244 - $14,758	396 New	396 $14,000

486

56.6M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.82B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.